Scabies Epidemiology Forecast 2025-2034

Scabies, a parasitic skin disease, is a major global public health issue, with approximately 455 million new cases reported annually. The condition is more prevalent in tropical regions with limited access to healthcare, where overcrowded living conditions and poor sanitation contribute to its spread.

Scabies Epidemiology Forecast Report Coverage

The “Scabies Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of scabies. It projects the future incidence and prevalence rates of scabies across various populations. The study covers age and type as major determinants of the scabies-affected population. The report highlights patterns in the prevalence of scabies over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of scabies in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Scabies: Disease Overview

Scabies is a highly contagious parasitic skin disease caused by the infestation of the mite Sarcoptes scabiei. It is spread through prolonged skin-to-skin contact, often in overcrowded living conditions. This skin infection can also be transmitted by sharing contaminated clothing, bedding, or towels. The primary symptoms of scabies include intense itching, redness, and rashes, usually in areas like the wrists, elbows, and between the fingers.

Scabies: Treatment Overview

The treatment for scabies primarily involves the use of topical medications that target mites. The most commonly prescribed treatment is permethrin cream, which is applied to the entire body. Oral ivermectin may be prescribed when topical treatments are ineffective or for severe infestations. Additionally, soothing treatments like antihistamines or corticosteroid creams may be recommended to manage itching and inflammation during recovery.

Epidemiology

The scabies epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for scabies by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for scabies and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Over 400 million people are affected by scabies each year worldwide.
• Studies show that scabies is highly prevalent in regions such as Africa, South America, Australia, and Southeast Asia. The high prevalence in these areas is closely linked to poverty, poor nutrition, homelessness, and inadequate hygiene.
• Scabies affects more than 200 million people globally at any time, accounting for a significant portion of skin diseases in low- and middle-income countries.
• Children are reported to have the greatest burden of scabies, with the highest prevalence observed in those under 2 years old.

Country-wise Scabies Epidemiology

The scabies epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of scabies varies significantly between countries due to factors like climate, socioeconomic conditions, access to healthcare, and living conditions, among others. In countries like the United States and other similar regions, scabies outbreaks are more common in places where people share living spaces, such as correctional facilities, nursing homes, or dormitories.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of scabies based on several factors.
• The Scabies Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of scabies are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of scabies epidemiology in the 8 major markets?
• What will be the total number of patients with scabies across the 8 major markets during the forecast period?
• What was the country-wise prevalence of scabies in the 8 major markets in the historical period?
• Which country will have the highest number of scabies patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of scabies during the forecast period of 2025-2034?
• What are the currently available treatments for scabies?
• What are the disease risks, signs, symptoms, and unmet needs of scabies?

This product will be delivered within 3-5 business days.